Kelli L. Palmer

6.2k total citations
86 papers, 4.4k citations indexed

About

Kelli L. Palmer is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Kelli L. Palmer has authored 86 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 40 papers in Infectious Diseases and 18 papers in Epidemiology. Recurrent topics in Kelli L. Palmer's work include Antimicrobial Resistance in Staphylococcus (30 papers), Bacterial biofilms and quorum sensing (18 papers) and Bacteriophages and microbial interactions (12 papers). Kelli L. Palmer is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (30 papers), Bacterial biofilms and quorum sensing (18 papers) and Bacteriophages and microbial interactions (12 papers). Kelli L. Palmer collaborates with scholars based in United States, Brazil and United Kingdom. Kelli L. Palmer's co-authors include Michael S. Gilmore, Marvin Whiteley, Marvin Whiteley, Veronica N. Kos, Breck A. Duerkop, Stacie A. Brown, Pradeep K. Singh, Karthik Hullahalli, Wenwen Huo and Danieli C. Rodrigues and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Kelli L. Palmer

83 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelli L. Palmer United States 33 2.4k 1.2k 725 716 621 86 4.4k
Xiaokui Guo China 40 2.2k 0.9× 1.0k 0.8× 994 1.4× 638 0.9× 325 0.5× 209 5.3k
Slade O. Jensen Australia 33 1.8k 0.8× 1.5k 1.3× 643 0.9× 1.4k 1.9× 435 0.7× 78 4.7k
Matthew Thoendel United States 21 2.0k 0.8× 931 0.8× 354 0.5× 357 0.5× 488 0.8× 32 3.3k
Blaise R. Boles United States 31 3.6k 1.5× 1.5k 1.2× 527 0.7× 378 0.5× 683 1.1× 36 5.0k
Barbara C. Kahl Germany 41 3.1k 1.3× 3.0k 2.4× 373 0.5× 1.1k 1.5× 638 1.0× 101 6.0k
Sünje Johanna Pamp Denmark 23 2.6k 1.1× 707 0.6× 419 0.6× 558 0.8× 423 0.7× 34 3.7k
Giovanni Di Bonaventura Italy 36 3.1k 1.3× 1.1k 0.9× 389 0.5× 765 1.1× 184 0.3× 119 6.3k
Jeffrey B. Kaplan United States 45 4.8k 2.0× 1.2k 0.9× 770 1.1× 452 0.6× 524 0.8× 83 7.1k
Gianfranco Donelli Italy 36 2.5k 1.0× 862 0.7× 289 0.4× 596 0.8× 330 0.5× 96 5.4k

Countries citing papers authored by Kelli L. Palmer

Since Specialization
Citations

This map shows the geographic impact of Kelli L. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelli L. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelli L. Palmer more than expected).

Fields of papers citing papers by Kelli L. Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelli L. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelli L. Palmer. The network helps show where Kelli L. Palmer may publish in the future.

Co-authorship network of co-authors of Kelli L. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Kelli L. Palmer. A scholar is included among the top collaborators of Kelli L. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelli L. Palmer. Kelli L. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durso, Lisa M., et al.. (2024). CRISPR-Cas inhibits plasmid transfer and immunizes bacteria against antibiotic resistance acquisition in manure. Applied and Environmental Microbiology. 90(9). e0087624–e0087624. 3 indexed citations
2.
3.
Guan, Ziqiang, et al.. (2024). Lipid discovery enabled by sequence statistics and machine learning. eLife. 13. 2 indexed citations
4.
Kim, Sol, Brady L. Spencer, Kelli L. Palmer, et al.. (2024). Streptococcus agalactiae glycolipids promote virulence by thwarting immune cell clearance. Science Advances. 10(22). eadn7848–eadn7848. 5 indexed citations
5.
Stellfox, Madison E., et al.. (2023). Targeted IS-element sequencing uncovers transposition dynamics during selective pressure in enterococci. PLoS Pathogens. 19(6). e1011424–e1011424. 13 indexed citations
7.
9.
Price, Valerie, et al.. (2021). Characterization of presumptive vancomycin-resistant enterococci recovered during infection control surveillance in Dallas, Texas, USA. Access Microbiology. 3(3). 214–214. 6 indexed citations
10.
11.
Wu, Xiaoqian, et al.. (2020). Chromosomal Resistance to Metronidazole in Clostridioides difficile Can Be Mediated by Epistasis between Iron Homeostasis and Oxidoreductases. Antimicrobial Agents and Chemotherapy. 64(8). 26 indexed citations
12.
Rodrigues, Marinelle, Sara W. McBride, Karthik Hullahalli, Kelli L. Palmer, & Breck A. Duerkop. (2019). Conjugative Delivery of CRISPR-Cas9 for the Selective Depletion of Antibiotic-Resistant Enterococci. Antimicrobial Agents and Chemotherapy. 63(11). 121 indexed citations
13.
Price, Valerie, Sara W. McBride, Karthik Hullahalli, et al.. (2019). Enterococcus faecalis CRISPR-Cas Is a Robust Barrier to Conjugative Antibiotic Resistance Dissemination in the Murine Intestine. mSphere. 4(4). 61 indexed citations
14.
Chatterjee, Anushila, Cydney N. Johnson, Karthik Hullahalli, et al.. (2019). Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci. Infection and Immunity. 87(6). 90 indexed citations
15.
Guan, Ziqiang, et al.. (2019). Phosphatidylcholine Biosynthesis in Mitis Group Streptococci via Host Metabolite Scavenging. Journal of Bacteriology. 201(22). 28 indexed citations
16.
Hullahalli, Karthik, et al.. (2018). An Attenuated CRISPR-Cas System in Enterococcus faecalis Permits DNA Acquisition. mBio. 9(3). 49 indexed citations
17.
Huo, Wenwen, et al.. (2018). A Type I Restriction-Modification System Associated with Enterococcus faecium Subspecies Separation. Applied and Environmental Microbiology. 85(2). 25 indexed citations
18.
Huo, Wenwen, et al.. (2018). Loss-of-Function Mutations in epaR Confer Resistance to ϕNPV1 Infection in Enterococcus faecalis OG1RF. Antimicrobial Agents and Chemotherapy. 62(10). 50 indexed citations
19.
Bhardwaj, Pooja, et al.. (2017). Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium after Serial Chlorhexidine Exposure. Antimicrobial Agents and Chemotherapy. 62(1). 67 indexed citations
20.
Hullahalli, Karthik, Marinelle Rodrigues, & Kelli L. Palmer. (2017). Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations. eLife. 6. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026